(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PRECIGEN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

PRECIGEN

ST13

US500000097819704

Class

1, 5, 42, 44, 45

Filing

97819704

Registration

7310349

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

11

Latest update

09/25/2025

Trademark type

Combined

Nice classes

1, 5, 42, 44, 45

Filing date

03/02/2023

Registration date

02/20/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/20/2024

Last transaction

09/25/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

01/06/2020

First use in commerce

01/06/2020

Drawing code

3

Owner type

03

Owner location

Germantown, MD

Examiner

ALESKOW, DAVID

Law office

L50

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the stylized wording "PRECIGEN" under the design of a triangle formed by a series of lines in different directions.

Holders and representatives

Holders

Precigen, Inc.

Representatives

SARAH P. HARRELL BARNES & THORNBURG LLP

Technical classification

Nice Classes

Class 1Class 5Class 42Class 44Class 45

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Chemicalsbiochemicals and reagents for use in industry and science; chemicalsbiochemicals and reagentsproteins for regulatingmodifying or restricting gene expression; kits consisting primarily of proteins for regulatingmodifying or restricting gene expression

Class 5

Chemical preparations for medical and veterinary purposesfor gene and cell therapy for treating genetic disorderscancersrare diseasesinfectious diseasesimmunological diseases and disorders; biochemical preparations for medical and veterinary purposesfor gene and cell therapy for treating genetic disorderscancersrare diseasesinfectious diseasesimmunological diseases and disorders; chemical reagents for medical and veterinary purposesfor gene and cell therapy for treating genetic disorderscancersrare diseasesinfectious diseasesimmunological diseases and disorders

Class 42

Scientific research and development services in the field of medicinepharmacologyimmunologybiochemistrycell biologygeneticsmicrobiology and virology; Scientific research in the field of healthcare; Therapeutic research of treatments in the fields of oncologyrare diseasesmetabolic disordersinfectious diseases which are under development or have completed development; Development of products being genetic therapiesbiopharmaceuticalseffectors to regulatemodulatecharacterize disease states; Development of tools in the nature of software and biotechnological processes to regulatemodulatecharacterize disease states; Research and development services for others in the field of biotechnologygenetically engineering DNAbiological organismscellsvirusespathogensspecial purpose cells for scientificresearchmedical and laboratory use; Research and development services for others in the fields of genetics and biotechnologygenetically engineering DNAbiological organismscellsvirusespathogensspecial purpose cells for scientificresearchmedical and laboratory use

Class 44

Medical services; Medical servicesgenetic engineeringbiopharmaceuticals and gene therapy services; Healthcare servicestreatment of patients with genetic disorderscancersrare diseasesinfectious diseasesimmunological diseases and disorders; Medical servicesproviding medical therapy treatments which are under development or have completed development for patients in the fields of oncologyrare diseasesmetabolic disordersinfectious diseases

Class 45

Technology transfer serviceslicensing of intellectual property

Publications

History of USPTO decisions and trademark events.

11 publications found

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

09/24/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

02/20/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

02/20/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/05/2023

PUBO

PUBLISHED FOR OPPOSITION

12/05/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/15/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/30/2023

DOCK

ASSIGNED TO EXAMINER

10/30/2023

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

03/23/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/22/2023

NWAP

NEW APPLICATION ENTERED

03/06/2023

Continuous trademark protection

Get notified about every new filing that threatens PRECIGEN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.